
zzso reduces the risk of zzso zzso zzso and is indicated as primary prophylaxis when the risk of zzso approaches zzso in each chemotherapy zzso There have been few reports evaluating the appropriate use of zzso in comparison with published zzso We sought to determine possible zzso as a way to maintain quality and reduce zzso 

A retrospective medical record review was performed to determine whether zzso was used appropriately in the primary prophylaxis of zzso in chemotherapy regimens with less than zzso risk of zzso Patients were identified by means of administrative records, and data were collected from the electronic medical record at an academic cancer center zzso clinic serving approximately 13,000 patients per zzso 

Two hundred zzso patients were identified, of whom 124 were initially evaluated and 88 were zzso zzso patients zzso had no risk factors, and 20 zzso had one risk factor that would justify zzso use with low- or zzso zzso The most common cancer diagnosis of patients with zero or one risk factor was lymphoma, and the most common regimens with overuse of zzso were zzso zzso and zzso zzso One hundred zzso zzso doses zzso were classified as zzso The cost to the health system for unnecessary drug use was zzso in 1 zzso 

At one institution, approximately one half of all primary prophylaxis zzso was not indicated per published zzso This represents an excellent opportunity to change prescribing practices to reduce costs without harming zzso 

